Vyome Therapeutics Ltd. Revenue and Competitors
Estimated Revenue & Valuation
- Vyome Therapeutics Ltd.'s estimated annual revenue is currently $2.3M per year.
- Vyome Therapeutics Ltd.'s estimated revenue per employee is $155,000
Employee Data
- Vyome Therapeutics Ltd. has 15 Employees.
- Vyome Therapeutics Ltd. grew their employee count by -12% last year.
Vyome Therapeutics Ltd.'s People
Name | Title | Email/Phone |
---|
Vyome Therapeutics Ltd. Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $8.5M | 55 | -21% | N/A | N/A |
#2 | $0.2M | 1 | 0% | N/A | N/A |
#3 | $8.5M | 55 | -29% | N/A | N/A |
#4 | $108.5M | 500 | 2% | N/A | N/A |
#5 | $0.8M | 5 | 0% | N/A | N/A |
#6 | $0.6M | 4 | 0% | N/A | N/A |
#7 | $14.7M | 68 | -23% | $206.4M | N/A |
#8 | $492.2M | 1503 | -15% | $568M | N/A |
#9 | $1.1M | 7 | -42% | N/A | N/A |
#10 | $4.5M | 29 | 0% | N/A | N/A |
What Is Vyome Therapeutics Ltd.?
Vyome Therapeutics Limited (VTL) is a 100% subsidiary of Vyome Therapeutics Inc (VTI) focused ondrug discovery and development services in the field of dermatology advancing the product pipeline of its parent company, VTI. VTL has a team of scientific and management experts with successful track record in the space of innovation and is currently prociding services to build VTI's robust pipeline of products. VTL has full service capabilities in the areas of Chemistry, Biology, Formulation development, Analytical development, Clinical research, and Quality Assurance. VTL laboratories are established in Delhi, India with the state-of-art infrastructure to carryout research and development services.
keywords:N/AN/A
Total Funding
15
Number of Employees
$2.3M
Revenue (est)
-12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.3M | 15 | -32% | N/A |
#2 | $1.3M | 15 | -6% | N/A |
#3 | $2.3M | 15 | 15% | N/A |
#4 | $1.3M | 15 | 25% | N/A |
#5 | $1.4M | 16 | 0% | N/A |